Advanced Glycation End Products Market Size at Highest Revenue US$ 2,130.1 Million with Growth Rate at 6.3% CAGR by 2027
SEATTLE , WASHINGTON, UNITED STATES, January 24, 2022 /EINPresswire.com/ -- Publisherโs Advanced Glycation End Products market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry Players.
๐๐ฅ๐จ๐๐๐ฅ ๐๐๐ฏ๐๐ง๐๐๐ ๐๐ฅ๐ฒ๐๐๐ญ๐ข๐จ๐ง ๐๐ง๐ ๐๐ซ๐จ๐๐ฎ๐๐ญ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐ซ๐ข๐ฏ๐๐ง ๐๐ฒ ๐๐ข๐ ๐ก ๐๐ซ๐๐ฏ๐๐ฅ๐๐ง๐๐ ๐จ๐ ๐๐ข๐๐๐๐ญ๐๐ฌ
Advanced Glycation End Products Market, by Type (Non-fluorescent AGEs (Carboxymethyl-lysine (CML), Carboxyethyl-lysine (CEL), and Pyrraline) and Fluorescent AGEs (Pentosidine and Methylglyoxal-lysine dimer (MOLD))), by Application (Diabetic Complications, Cancer, Bone Diseases, Neurodegenerative Diseases, and Others), by End User (Hospitals, Specialty Clinics, and Homecare Settings), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 2,130.1 Million in 2021 and is expected to exhibit a CAGR of 6.3% over the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.
๐๐จ ๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐๐ญ๐๐ฌ๐ญ ๐๐จ๐ฏ๐ข๐๐๐ ๐๐ฆ๐ฉ๐๐๐ญ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ @ https://www.coherentmarketinsights.com/insight/request-sample/4350
๐๐๐ซ๐ค๐๐ญ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ:
Advanced glycation end products are proteins or lipids that become glycated after exposure to sugars. Irreversible nonenzymatic reactions between reducing sugars, such as glucose, and amino groups in proteins, lipids, and nucleic acids helps to form advanced glycation end products. Recent studies have found link between advanced glycation end products and liver cancer. In May 2021, researchers at the International Agency for Research on Cancer in Lyon, France, high AGEs intake increases risk for gallbladder cancer.
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐:
Major players operating in the global advanced glycation end products market include, Allergan Plc, Beiersdorf AG, Estรฉe Lauder Companies, L'Orรฉal S.A, NuFACE, Ostium Cosmetics, PhotoMedex, Inc., Rodan & Fields, LLC, and Shiseido Company.
๐๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ:
High prevalence of diabetes is expected to propel growth of the global advanced glycation end-products market over the forecast period. For instance, according to the study, โGlobal Prevalence of Type 2 Diabetes over the Next Ten Years (2018-2028)โ, published by the American Diabetes Association, 500 million people worldwide suffered from type 2 diabetes in 2018.
๐๐จ ๐๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ ๐๐ซ๐จ๐๐ก๐ฎ๐ซ๐ ๐๐๐ซ๐ @ https://www.coherentmarketinsights.com/insight/request-pdf/4350
๐๐จ๐ฏ๐ข๐-๐๐ ๐๐ฆ๐ฉ๐๐๐ญ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ
Globally, as of 6:04pm CET, 12 January 2022, there have been 312,173,462 confirmed cases of COVID-19, including 5,501,000 deaths, reported to WHO. As of 11 January 2022, a total of 9,194,549,698 vaccine doses have been administered. In November 2020, vTv Therapeutics Inc. reported baseline characteristics for the enrolled subjects in the ongoing Elevage clinical study of azeliragon as a potential treatment for mild Alzheimerโs disease in people with type 2 diabetes. Approximately 35% of patients with Alzheimerโs disease have type 2 diabetes, with associated increased advanced glycation end products and increased expression of the Receptor for Advanced Glycation End products, the target for azeliragon.
๐๐๐ฒ ๐๐๐ค๐๐๐ฐ๐๐ฒ๐ฌ
Major players operating in the global advanced glycation end products market are focused on adopting partnership strategies to expand their product portfolio. For instance, in June 2021, vTv Therapeutics Inc. entered into a licensing agreement with Cantex Pharmaceuticals, Inc. under which Cantex obtained exclusive worldwide rights to develop and commercialize azeliragon, vTvโs novel antagonist of RAGE (the receptor for advanced glycation endproducts).
๐๐ฎ๐ฒ ๐๐จ๐ฐ ๐๐ง๐ ๐๐๐ญ ๐ ๐ฅ๐๐ญ ๐๐๐ ๐๐๐๐ ๐๐ ๐
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐จ ๐๐๐๐๐ฌ๐ฌ ๐ ๐ฎ๐ฅ๐ฅ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง @ https://www.coherentmarketinsights.com/promo/buynow/4350
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Mr. Shah
Coherent Market Insights Pvt. Ltd.
+1 206-701-6702
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Other